Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00248300 · ClinicalTrials.gov registry record · Phase 4
A Peri-intubation Oral Intervention to Reduce Oral Flora and VAP
A Phase 4 study of Pneumonia, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 4
- Development phase
- 156
- Enrollment target
- 1
- Study location
NCT00248300 is a Phase 4 study of Pneumonia that has completed, run by Virginia Commonwealth University. The registered enrollment target is 156 participants, below the 4,516-participant average among 47 other Pneumonia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00248300, a Phase 4 study of Pneumonia, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 156 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is determine if a single, early dose of chlorhexidine applied within 12 hours after endotracheal tube insertion will reduce the bacteria in the oral cavity and the incidence of pneumonia in trauma victims.
Conditions Studied
Interventions
- OTHER Chlorhexidine
Study Locations (1)
Virginia
- Virginia Commonwealth University School of Nursing - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2005-08 |
| Est. Completion | 2008-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00248300
The ClinicalTrials.gov registry entry for NCT00248300 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,516-participant average among 47 other Pneumonia trials with a reported enrollment target (97% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pneumonia appearing as the primary indexed condition, and to 1 intervention - of which Chlorhexidine is the first listed.
NCT00248300 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT00248300 about?
NCT00248300 is a clinical study titled "A Peri-intubation Oral Intervention to Reduce Oral Flora and VAP". The purpose of this study is determine if a single, early dose of chlorhexidine applied within 12 hours after endotracheal tube insertion will reduce the bacteria in the oral cavity and the incidence of pneumonia in trauma victims.
What is the current status of trial NCT00248300?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 156 participants. The study started on 2005-08. Estimated completion is 2008-08.
What conditions does trial NCT00248300 study?
This clinical trial studies the following conditions: Pneumonia.
What interventions are being tested in trial NCT00248300?
The interventions under investigation include: Chlorhexidine (OTHER).
Who is sponsoring clinical trial NCT00248300?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00248300 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pneumonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Multicenter Infection Surveillance Study Following Open Heart Surgery
COMPLETED · Phase 4
-
The APS Phenotyping Study
RECRUITING
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
Extending Dental Care to Nursing Home Residents to Reduce Mouth Infections and Incidence of Pneumonia and Improve Diabetic Glucose Control
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.